(Q46117943)

19 December 2017

editorial

0 references

title

Evaluation of response: is 18F-FDG PET the answer? (English)

1 reference

19 December 2017

author

Arturo Chiti

series ordinal

1

1 reference

19 December 2017

publication date

1 May 2009

1 reference

19 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

19 December 2017

volume

36

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

733-734

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-009-1092-2

exact match

0 references

cites work

Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction

1 reference

12 December 2020

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

12 December 2020

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

1 reference

12 December 2020

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.

1 reference

12 December 2020

Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.

1 reference

12 December 2020

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

12 December 2020

(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response.

1 reference

12 December 2020

Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer

1 reference

12 December 2020

Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus.

1 reference

12 December 2020

18F-FDG PET and PET/CT in the evaluation of cancer treatment response

1 reference

12 December 2020

The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment

1 reference

12 December 2020

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

1 reference

12 December 2020

10.1007/S00259-009-1092-2

Identifiers

DOI

1 reference

19 December 2017

1 reference

19 December 2017